Active Protocols

To contact our office, please use the information above. To contact an individual, please refer to the following contact information.

For further information about a particular protocol, contact the investigators.

Search by:

Query:

Total protocols available: 67. Viewing page 1 of 4.

First | Prev | Next | Last

Records per page:

Protocol	PI	Contact	Title
00-0156	Patrick McNamara	859 257-8656	Transport gene expression and drugs in milk
00-0464	Edward Kasarsakis	859 323-6702 x251	Assessment of Caloric Needs in ALS
01-0136	William Markesbery	859 323-6040	PREADVISE
02-0148	Debra Moser	859 323-6687	Biobehavioral intervention in Heart failure
020190P2B	Craig S. Miller	323-5598	Detection of Analytes in Saliva: Correlates with Human Disease (Salivary Cytokines and Periodontal Disease Diagnosis)
02-0209	Creed Pettigrew	859 257-5560	WARCEF: Warfarin vs Aspirin in Reduced Cardiac Ejection Fraction
02-0594	Wendell Akers	859 323-5055	Study of the safety of clopidrogel in combination with aspirin after off pump coronary artery bypass surgery
02-0685	Edward Kasarsakis	859 323-6702 x251	Phase III Trial of Minocycline in Amyotrophic Lateral Sclerosis
03-0035	Debra Moser	859 323-6687	Physiologic and Behavioral Mechanisms Linking Depression w/ Increased Morbidity and Mortality in Patients w/ Heart Failure
03-0041	Joseph Berger	323-1279	JCV expression during treatment with MS disease modifying drugs
03-0127-F2L	Paul D. Depriest	859 323-5277	Biomarker Discovery in Ovarian Tumors and Other Gynecological Conditions
03-0324	Larry Cunnigham	859 323-5219	Inflamatory Mediator Levels in Patients with Advanced Periodical Disease Before and After Full Mouth Extraction
03-0338	Charles D. Smith	859 323-6702 x246	The Alzheimer's Disease Genetics Initiative: The Multiplex Family Study
03-0463	Anand Vaishnav		Secondary Prevention of Small Subcortical Stokes (SPS3)
03-0509	Craig Rush	859-323-6130	University of Kentucky Laboratory of Human Behavioral Pharmacology screening
03-0561	Howard Diana	859 323-5768	A Phase I study using Bortzomid(Vacade) with weekly Idarubicin for the treatment of elderly and relapsed patients with acute Myeloid Leukemia
04-0044	Heidi Holmes	7-1450 ext 80198	Reconciling Biophysical and Psychosocial Models of Stress in Relocation among Older Women
04-0322	Jeff Ebersole/Karen Novak	323-8705	Gestational Diabetes Mellitus: Impact on Oral Health
04-0339	Dolph Dawson	323-4735	Project 5:Oral Infections: Dietary Regulation of Local and Systemic Inflammatory Responses
04-0417-F2L	Edward Kasarsakis	859 323-6702 x251	Early Treatment of ALS with Nutrition and NIPPV

The UK GCRC is funded by National Center for Research Resources
National Institutes of Health M01 RR02602